Needle Free Diabetes Care Market by Device Type (Insulin Infuser, Insulin Patches, Insulin Pens), End User (Consumer, Diagnostic Center, Hospitals & Clinic) - Global Forecast 2024-2030

Needle Free Diabetes Care Market by Device Type (Insulin Infuser, Insulin Patches, Insulin Pens), End User (Consumer, Diagnostic Center, Hospitals & Clinic) - Global Forecast 2024-2030


The Needle Free Diabetes Care Market size was estimated at USD 13.87 billion in 2023 and expected to reach USD 16.11 billion in 2024, at a CAGR 16.26% to reach USD 39.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Needle Free Diabetes Care Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Needle Free Diabetes Care Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Needle Free Diabetes Care Market, highlighting leading vendors and their innovative profiles. These include Akra Dermojet, Antares Pharma, Inc., Bioject Medical Technologies Inc., Echo Therapeutics Inc., European Pharma Group BV, Injex Pharma AG, MannKind Corporation, Medical International Technology, Inc., Pharmajet, Inc., and The 3M Company.

Market Segmentation & Coverage

This research report categorizes the Needle Free Diabetes Care Market to forecast the revenues and analyze trends in each of the following sub-markets:

Device Type

Insulin Infuser

Insulin Patches

Insulin Pens

Insulin Pumps

Jet Injectors
End User

Consumer

Diagnostic Center

Hospitals & Clinic
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Needle Free Diabetes Care Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Needle Free Diabetes Care Market?
3. What are the technology trends and regulatory frameworks in the Needle Free Diabetes Care Market?
4. What is the market share of the leading vendors in the Needle Free Diabetes Care Market?
5. Which modes and strategic moves are suitable for entering the Needle Free Diabetes Care Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Needle Free Diabetes Care Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of diabetes and obese population
5.1.1.2. Increasing number of smartphone apps for disease management
5.1.1.3. Rising awareness regarding the disease and the treatments
5.1.2. Restraints
5.1.2.1. High cost associated with the facility and concerns regarding technical errors
5.1.3. Opportunities
5.1.3.1. Technological advancements for diabetes care
5.1.3.2. Growing adoption of needle-free diabetes management
5.1.4. Challenges
5.1.4.1. High risk of infection because of poking and needle-stick injuries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Needle Free Diabetes Care Market, by Device Type
6.1. Introduction
6.2. Insulin Infuser
6.3. Insulin Patches
6.4. Insulin Pens
6.5. Insulin Pumps
6.6. Jet Injectors
7. Needle Free Diabetes Care Market, by End User
7.1. Introduction
7.2. Consumer
7.3. Diagnostic Center
7.4. Hospitals & Clinic
8. Americas Needle Free Diabetes Care Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Needle Free Diabetes Care Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Needle Free Diabetes Care Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Akra Dermojet
12.1.2. Antares Pharma, Inc.
12.1.3. Bioject Medical Technologies Inc.
12.1.4. Echo Therapeutics Inc.
12.1.5. European Pharma Group BV
12.1.6. Injex Pharma AG
12.1.7. MannKind Corporation
12.1.8. Medical International Technology, Inc.
12.1.9. Pharmajet, Inc.
12.1.10. The 3M Company
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. NEEDLE FREE DIABETES CARE MARKET RESEARCH PROCESS
FIGURE 2. NEEDLE FREE DIABETES CARE MARKET SIZE, 2023 VS 2030
FIGURE 3. NEEDLE FREE DIABETES CARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEEDLE FREE DIABETES CARE MARKET DYNAMICS
FIGURE 7. NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
FIGURE 8. NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 10. NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. NEEDLE FREE DIABETES CARE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. NEEDLE FREE DIABETES CARE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings